Neuroblastoma destroy the body by attacking the nervous technique. Although comparatively rare, this type of cancer is the reason for about three percent of cancer cases in children & 15 percent of non-adult cancer deaths. About two-thirds of cases of this type of cancer can not be diagnosed & often found already spread to several parts of the body organs.
As published online edition of the journal Nature Medicine, researchers from Baylor College of Medicine in Houston to generate these immune cells by adding an artificial receptor (artificial) on T lymphocytes & enhance their ability to fight deadly kind of cancer called neuroblastoma.
Naturally, T lymphocytes are unable to survive as long as well as loss of molecules that function against cancer cells in tumors. To overcome these shortcomings, the research team led by Malcolm Brenner of Baylor College of Medicine in Illinois developed immune cells, called cell super-charge.
Tues tremendous was developed from the immune cells that are naturally stimulated or dirangang by a virus that is harmless called Epstein-Barr. Specialists modifying these cells to generate a key receptor type of protein present in human neuroblastoma cells.
"For the first time, they began to see the response to the tumor. They have seen the ideal remission in case, while the other stable disease for a year, "he said.
From the results of a study of 11 patients with neuroblastoma aged two to ten years, cells engineered kekabalan can survive up to 18 months. In cases, the tumor showed regression & sixth cases even healed.
For future research, Brenner & his team plan to add a receptor to other types of cancer cells to see if it also creates a similar effect in blocking cancer.
No comments:
Post a Comment